Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zilli

Showing results (141-150 of 234) with videos related to

Pageof 24
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2017
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancerWulfran Cacheux, Thibaud Koessler, Giacomo Puppa, et al.
Radiation Oncology (London, England)|December 26, 2008
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaDamien C Weber, Thomas Zilli, Franz Buchegger, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2020
Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation TherapySophie Robin, Marjory Jolicoeur, Samuel Palumbo, et al.
Critical Reviews in Oncology/Hematology|August 5, 2019
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancerFrédéric Amestoy, Guilhem Roubaud, Mikaël Antoine, et al.
Acta Oncologica (Stockholm, Sweden)|June 16, 2020
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic reviewVerane Achard, Marta Bottero, Michel Rouzaud, et al.
Clinical Nuclear Medicine|February 28, 2017
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate CancerGiorgio Lamanna, Claire Tabouret-Viaud, Olivier Rager, et al.
Radiation Oncology (London, England)|June 21, 2018
Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?Angèle Dubouloz, Michel Rouzaud, Lev Tsvang, et al.
Clinical and Translational Radiation Oncology|September 2, 2025
Treatment approaches for non-metastatic small cell bladder cancer: a meta-analysis of reconstructed Kaplan-Meier curvesLucas Mose, Priyamvada Maitre, Pascal Eberz, et al.
Prostate Cancer and Prostatic Diseases|June 19, 2024
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancerJennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 TrialThomas Zilli, Sandra Jorcano, Samuel Bral, et al.
Pageof 24

Showing results (141-150 of 234) with videos related to

Sort By:
Pageof 24
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2017
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancerWulfran Cacheux, Thibaud Koessler, Giacomo Puppa, et al.
Radiation Oncology (London, England)|December 26, 2008
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaDamien C Weber, Thomas Zilli, Franz Buchegger, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2020
Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation TherapySophie Robin, Marjory Jolicoeur, Samuel Palumbo, et al.
Critical Reviews in Oncology/Hematology|August 5, 2019
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancerFrédéric Amestoy, Guilhem Roubaud, Mikaël Antoine, et al.
Acta Oncologica (Stockholm, Sweden)|June 16, 2020
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic reviewVerane Achard, Marta Bottero, Michel Rouzaud, et al.
Clinical Nuclear Medicine|February 28, 2017
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate CancerGiorgio Lamanna, Claire Tabouret-Viaud, Olivier Rager, et al.
Radiation Oncology (London, England)|June 21, 2018
Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?Angèle Dubouloz, Michel Rouzaud, Lev Tsvang, et al.
Clinical and Translational Radiation Oncology|September 2, 2025
Treatment approaches for non-metastatic small cell bladder cancer: a meta-analysis of reconstructed Kaplan-Meier curvesLucas Mose, Priyamvada Maitre, Pascal Eberz, et al.
Prostate Cancer and Prostatic Diseases|June 19, 2024
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancerJennifer Le Guevelou, Francesco Cuccia, Ronan Flippot, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 TrialThomas Zilli, Sandra Jorcano, Samuel Bral, et al.
Pageof 24